TTAB Oppositions 91272456
USPTO Oppositions proceeding 91272456, filed 2021-10-22. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91272456 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2021-10-22 |
| Last Activity | 2022-07-26 |
| Days Active | 1666 |
Parties
- Primus Pharmaceuticals, Inc. — Defendant
- Teva Pharmaceutical Industries Ltd. — Plaintiff
Plaintiff Marks
- COPAXONE — Teva Pharmaceutical Industries Ltd.
- COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY — Teva Pharmaceutical Industries Ltd.
- COPAXONE CO-PAY SOLUTIONS — Teva Pharmaceutical Industries Ltd.
- COPAXONE ITRACKER — Teva Pharmaceutical Industries Ltd.
- COPAXONE WEBTRACKER — Teva Pharmaceutical Industries Ltd.
Defendant Marks
- MODAXXONE — Primus Pharmaceuticals, Inc.
Recent Documents
- 2022-07-26: TERMINATED — Status
- 2022-07-26: BD DECISION: OPP SUSTAINED — Decisions
- 2022-07-25: W/DRAW OF APPLICATION — Withdrawals
- 2021-12-30: EXTENSION OF TIME GRANTED — Extensions
- 2021-12-30: P MOT FOR EXT W/ CONSENT — Motions
- 2021-12-01: ANSWER — Pleadings
- 2021-10-22: INSTITUTED — Status
- 2021-10-22: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2021-10-22: FILED AND FEE — Fees